9-Nitrominocycline sulfate
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Pharmaceutical Intermediates
SuZhou Lanxite Biotechnology Co.,Ltd.
- Country / Year Established
-
China
/
- Business type
- Others
- Verified Certificate
-
13
| Product name | 9-Nitrominocycline sulfate | Certification | - |
|---|---|---|---|
| Category | Pharmaceutical Intermediates | Ingredients | - |
| Keyword | tigecycline , 9-nitrominocycline sulfate , tigecycline intermediate | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
Part No. :Tigecycline inter-1
Product:9-Nitrominocycline sulfate
Molecular Formula :C23H26N4O9.H2SO4
Molecular Weight :600.56
Quality standard: in-house standard
Assay: 99.5 %
Package: 25KG
Valid: 2 years
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
SuZhou Lanxite Biotechnology Co.,Ltd.
- Country / Year Established
-
China
/
- Business type
- Others
-
13
- President
- Vigoss
- Address
- Floor of Building A, No. 31 North Dongwu Rd., Suzhou city, P.R.C
- Product Category
- Pharmaceutical Intermediates
- Company introduction
-
Lanxite is focusing on API and intermediates, most business of which are subcontract and custom product service. After years effort, we have had a series of competitive products, a trained team and made success in some field. Welcome all the pharmaceutical and chemical company visit us and cooperate with us.
Our main business as follow:
API (active pharmaceutical ingredient)
Pharmaceuticals intermediates
Fine chemicals
- Main Product
Related Products
Cas 24131-07-5
Betamethasone 17-valerate
2,3,4,4'-Tetrehydroxybenzophenone, CAS NO.: 31127-54-5
Drug, medicine, API, pharmaceutical raw material, surgical dressing
Cas 160149-03-1
